Sobuzoxane

C22H34N4O10

sobuzoxane, 98631-95-9, MST 16, MST-16, [4-[2-[4-(2-methylpropoxycarbonyloxymethyl)-3,5-dioxopiperazin-1-yl]ethyl]-2,6-dioxopiperazin-1-yl]methyl 2-methylpropyl carbonate, DTXSID5045203, Perazolin, R1308VH37P, Sobuzoxane (JAN), NCGC00015954-02, SOBUZOXANE [JAN], Sobuzoxano, Sobuzoxanum, Sobuzoxane [INN:JAN], Sobuzoxanum [INN-Latin], 4,4'-(1,2-Ethanediyl)bis(1-iso-butoxycarbonyloxmethyl-2,6-piperazinedione), Sobuzoxano [INN-Spanish], BRN 6031322, UNII-R1308VH37P, Perazolin (TN), SOBUZOXANE [MI], SOBUZOXANE [INN], Lopac-S-4692, 1,2-Bis(4-isobutoxycarbonyloxymethyl-3,5-dioxo-piperazin-1-yl)ethane, SOBUZOXANE [MART.], 4,4'-Ethylenebis(1-(hydroxymethyl)-2,6-piperazinedione) bis(isobutyl carbonate) (ester), SOBUZOXANE [WHO-DD], Lopac0_001094, SCHEMBL18416, MLS002153414, CHEMBL1256871, DTXCID3025203, CHEBI:32136, HMS2230C04, HMS3263K10, HMS3369L07, Tox21_110265, Tox21_501094, MFCD00866498, Sobuzoxane, >=99% (HPLC), solid, CCG-205171, LP01094, SDCCGSBI-0051064.P002, NCGC00015954-01, NCGC00015954-03, NCGC00015954-04, NCGC00094367-01, NCGC00094367-02, NCGC00261779-01, Carbonic acid, 1,2-ethanediylbis((2,6-dioxo-4,1-piperazinediyl)methylene)bis(2-methylpropyl) ester, SMR001230790, CAS-98631-95-9, EU-0101094, 1-N-TRITYL-IMIDAZOLE-2-YLPROPIONICACID, D01404, F52515, S 4692, A839107, SR-01000075401, SR-01000075401-2, Q27287640, 4,4'-(1,2-Ethanediyl)bis(1-isobutoxycarbonyloxmethyl-2,6-piperazinedione), 4,4'-(1,2-Ethanediyl)bis(1-isobutoxycarbonyloxymethyl-2,6-piperazinedione), (4,4'-(ethane-1,2-diyl)bis(2,6-dioxopiperazine-4,1-diyl))bis(methylene) isobutyl dicarbonate, [4-[2-[4-(2-methylpropoxycarbonyloxymethyl)-3,5-bis(oxidanylidene)piperazin-1-yl]ethyl]-2,6-bis(oxidanylidene)piperazin-1-yl]methyl 2-methylpropyl carbonate, [4-[2-[4-(2-Methylpropoxycarbonyloxymethyl)-3,5-dioxo-piperazin-1-yl]ethyl]-2,6-dioxo-piperazin-1-yl]methyl 2-methylpropyl carbonate, carbonic acid [4-[2-[4-[[2-methylpropoxy(oxo)methoxy]methyl]-3,5-dioxo-1-piperazinyl]ethyl]-2,6-dioxo-1-piperazinyl]methyl

Sobuzoxane is  classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate